Mr. Ralph Olson reports

DOSEOLOGY UPLISTS TO OTCQB MARKET IN USA

Doseology Sciences Inc. has received approval of its application for an uplisting to the OTCQB Venture Market in the United States. The company's common shares will commence trading on the OTCQB on July 6, 2022, under the symbol DOSEF.

"Uplisting is another important milestone towards broadening our market presence across the United States as we engage with our increasingly global investor base," said Ralph Olson, chief executive officer of the company. "The OTCQB positions Doseology with increased visibility among the American investment community and improved liquidity for our current and prospective shareholders."

The shares will continue trading on the Canadian Securities Exchange under the symbol MOOD and on the Frankfurt Stock Exchange under the symbol VU7. Investors can find real-time quotes and market information for the company on the OTC Markets website.

About Doseology Sciences Inc.

Doseology Sciences is building a progressive brand focused on mental health and wellness through cultivation, extraction and innovative nutraceutical and pharmaceutical products. Doseology aims to make a meaningful impact on the mental health pandemic by utilizing and developing functional fungi and plant-derived drugs. With a vertically integrated approach, Doseology intends to process and distribute products at its facilities in Vernon, B.C., in accordance with applicable laws to ensure safe and high-quality production. Doseology's medicinal mushroom products, including tinctures, powders and supplements, are available on the Doseology website.

We seek Safe Harbor.